Trebananib Terminated Phase 3 Trials for Fallopian Tube Cancer / Primary Peritoneal Cancer / Ovarian Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01281254AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)